FIELD: medicine.
SUBSTANCE: group of inventions relates to reconstructive or aesthetic dermatological treatment. Composition for dermatological treatment contains microspheres or microparticles of at least one polymer of non-animal origin in amount of 5 mg/ml to 50 mg/ml, which have a size of about 20 mcm to 100 mcm and a molecular weight of polymer from 50 kDa to 500 kDa, where at least one polymer contains a dairy polymer acids; hydrogel containing water and gelling agent based on cellulose derivative, where the gelling agent based on the cellulose derivative is present in amount of 1% to 3% by weight and is selected from carboxymethyl cellulose and hydroxypropyl methyl cellulose; polysorbate 80 in amount of 0.05% to 1% by weight. Also disclosed are a pre-filled syringe, a bottle, an injection implant for performing a reconstructive or aesthetic dermatological treatment and a method for carrying out the reconstructive or aesthetic dermatological treatment.
EFFECT: group of inventions provides stabilization of the product ready for use during storage.
39 cl, 10 dwg, 4 tbl, 6 ex
Title |
Year |
Author |
Number |
INJECTABLE COMPOSITION WITH SUSPENDED RELEASE CONTAINING A CONJUGATE OF A FILLER WITH POLY-L-LACTIC ACID, A FILLER WITH HYALURONIC ACID AND A BIOACTIVE MATERIAL, AND A METHOD FOR ITS PREPARATION |
2020 |
|
RU2777623C1 |
INJECTION COMPOSITION CONTAINING A CONJUGATE OF FILLER WITH POLY-L-LACTIC ACID AND FILLER WITH HYALURONIC ACID, AND METHOD OF ITS PREPARATION |
2020 |
|
RU2777622C1 |
DERMAL FILLER BASED ON CROSS-LINKED HYALURONIC ACID AND CARBOXYMETHYL CELLULOSE AS LUBRICANT |
2015 |
- El-Banna, Radia
- Belkovi, Lubin
- Stragies, Roland
- Hagedorn, Nadine
- Villain, Franck
|
RU2712641C2 |
DELAYED-RELEASE INJECTION COMPOSITION CONTAINING A CONJUGATE OF A FILLER WITH POLY-L-LACTIC ACID AND A FILLER WITH HYALURONIC ACID, AND METHOD FOR PRODUCTION THEREOF |
2020 |
|
RU2777621C1 |
IMPLANT FOR SUBCUTANEOUS OR INTRACUTANEOUS INJECTION |
1998 |
- Azijus Zherom
- Fessi Atem
- Gushe Frank
- Laglenn Benedikt
- Lozh'E-Laglenn Ehlizabet
|
RU2214283C2 |
COMPOSITION AND METHODS FOR TREATMENT OR PROPHYLAXIS OF INFLAMMATORY DISEASES |
1997 |
|
RU2242974C2 |
BIODEGRADABLE, SEMI-CRYSTALLINE, PHASE SEPARATED, THERMOPLASTIC MULTI-BLOCK COPOLYMERS FOR CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS |
2012 |
- Stendam Rob
- Flipsen Teodorus Adrianus Kornelius
- Khimstra Kristin
- Zejdema Jokhan
|
RU2662818C2 |
MEDICINAL AGENTS WITH CONTROLLED RELEASE BASED ON BLOCK-COPOLYMERS |
2006 |
- Beshe Ann Shantal'
- Van Dejkkhejzen-Radersma Rimke
- Stigter Martin
- Bezemer Erun Mattejs
|
RU2409348C2 |
COMPOSITION FOR SUSTAINED-RELEASE OF HUMAN GROWTH HORMONE |
1996 |
- Dzhonson Olafanmi Lili
- Ganmukkhi Medkha M.
- Bernstajn Govard
- Auehr Genri
- Khan M. Amin
|
RU2161502C2 |
SOLID PHASE METHOD FOR PRODUCTION OF BIOACTIVE COMPOSITE FOR TISSUE GROWING BASED ON HYALURONIC ACID OR POLYLACTIDE MICROPARTICLES AND ITS COPOLYMERS, AND METHOD FOR MANUFACTURE OF IMPLANT BASED ON THIS COMPOSITE |
2016 |
- Mikhajlova Natalya Pavlovna
- Selyanin Mikhail Anatolevich
- Uspenskij Sergej Alekseevich
|
RU2641053C1 |